Open, Prospective, Multi-Center, Two-Part Study of Patient Preference with Monthly Ibandronate Therapy in Women with Postmenopausal Osteoporosis Switched From Daily or Weekly Alendronate or Risendronate-BONCURE: Results of Turkish Sub-Study
Aim: BONCURE (Bonviva for Current Bisphosphonate Users Regional European Trial), aimed to evaluate patient preference with monthly ibandronate in women with postmenopausal osteoporosis who previously received daily or weekly alendronate or risendronate. Materials and Methods: This prospective, ope...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Turkish Society of Osteoporosis
2012-04-01
|
| Serija: | Türk Osteoporoz Dergisi |
| Teme: | |
| Online pristup: | http://www.turkosteoporozdergisi.org/article_4291/Open-Prospective-Multi-center-Two-part-Study-Of-Patient-Preference-With-Monthly-Ibandronate-Therapy-In-Women-With-Postmenopausal-Osteoporosis-Switched-From-Daily-Or-Weekly-Alendronate-Or-Risendronate-boncure-Results-Of-Turkish-Sub-study |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|